Two members of Congress — Rep. Elijah Cummings (D-Md.) and Sen. Bernie Sanders (I-Vt.) — have asked three generic drug makers for documents as part of an investigation into price hikes, renewing an effort the lawmakers first began in 2014.

In letters to Mylan (MYL), Teva Pharmaceutical (TEVA), and Heritage Pharmaceuticals, Cummings and Sanders also asked for information about allegations the companies apparently attempted to “stonewall” their 2014 probe (read the letters here, here, and here). The allegations surfaced this past May in a price-fixing lawsuit that was filed by 44 state attorneys general against 20 generic drug makers.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy